Related Experiment Video
Updated: Jan 3, 2026
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Role of Surgery for Metastatic Melanoma
Laura M Enomoto1, Edward A Levine1, Perry Shen1
1Department of Surgery, Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston Salem, NC 27157, USA.
Abstract:
Complete surgical resection of metastatic melanoma has a known survival benefit. Treatment of metastatic melanoma, however, has become increasingly complex with the introduction of targeted treatments and immune checkpoint inhibitors. Integration of systemic medical therapy and surgical resection has shown promising results, with significantly improved long-term survivals. Results from current clinical trials are awaited to help further delineate the sequence and combination of systemic therapy and surgery.
Insights
Complete surgical resection improves survival for metastatic melanoma. Combining surgery with new systemic therapies like targeted treatments and immune checkpoint inhibitors shows promising long-term survival benefits, with ongoing trials to refine optimal treatment sequencing.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Oncology
Background:
- Metastatic melanoma treatment is evolving with targeted therapies and immune checkpoint inhibitors.
- Complete surgical resection of metastatic melanoma is a recognized method for improving patient survival.
- The optimal integration of systemic therapies and surgery remains an area of active investigation.
Purpose of the Study:
- To review the current landscape of metastatic melanoma treatment.
- To evaluate the role of surgical resection in conjunction with modern systemic therapies.
- To highlight the emerging benefits of combined-modality treatment approaches.
Main Methods:
- Review of current literature and clinical trial data.
- Analysis of survival outcomes in patients undergoing surgical resection for metastatic melanoma.
- Assessment of treatment sequencing and combination strategies.
Main Results:
- Surgical resection of metastatic melanoma offers a survival advantage.
- Integration of systemic medical therapy with surgical resection demonstrates significantly improved long-term survival.
- Current clinical trials are investigating optimal combinations and timing of therapies.
Conclusions:
- Combined-modality treatment, including surgery and systemic therapy, offers a promising approach for metastatic melanoma.
- Further research and clinical trials are essential to establish definitive treatment guidelines.
- Personalized treatment strategies integrating surgery and systemic therapies are key to improving outcomes.
